We hypothesize that use of postoperative heparin deep vein thrombosis prophylaxis influences development of surgical site infection (SSI) after colorectal surgery. From July 2008 to June 2009, patients undergoing an abdominal operation by colorectal surgeons at a single university-affiliated teaching hospital were prospectively followed and more than 80 variables collected. One hundred eighty-one patients were identified. Forty-five per cent (n = 82) received heparin prophylaxis and 55 per cent (n = 99) did not. SSI occurred in 23 per cent (n = 19) of patients receiving heparin versus 9 per cent (n = 9) who did not (P = 0.02). Univariate analysis found SSI to be associated with heparin (P = 0.02) and increased operative time (P = 0.03). Multivariate analysis showed that SSI was associated only with heparin use (P = 0.04; OR, 2.6; 95% CI, 1.1 to 6.6).
Get full access to this article
View all access options for this article.
References
1.
GeertsW.H., BergqvistD., PineoG.F.Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).Chest2008; 133: 381S–453S.
2.
CapriniJ.A.Risk assessment as a guide for the prevention of the many faces of venous thromboembolism.Am J Surg2010; 199(Suppl): S3–10.
3.
HeitJ.A., CohenA.T., AndersonF.A.Estimated annual number of incident and recurrent, non-fatal and fatal venous thromboembolism (VTE) events in the US.Blood2005; 10: 910.
PatelV., WalshM., SehgalB.Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty.J Bone Joint Surg Am2007; 89: 33–8.
6.
Sanchez-BallesterJ., SmithM., HassanK.Wound infection in the management of hip fractures: a comparison between low-molecular weight heparin and mechanical prophylaxis.Acta Orthop Belg2005; 71: 55–9.
7.
AsenioA., RamosA., MunezE.Preoperative low molecular weight heparin as venous thromboembolism prophylaxis in patients at risk for prosthetic infection after knee arthroplasty.Infect Control Hosp Epidemiol2005; 26: 903–9.
TaskerA., HarbordR., BannisterG.C.Meta-analysis of low molecular weight heparin versus placebo in patients undergoing total hip replacement and post-operative morbidity and mortality since their introduction.Hip Int2010; 20: 64–74.
10.
MuntzJ.E., MichotaF.A.Prevention and management of venous thromboembolism in the surgical patient: options by surgery type and individual patient risk factors.Am J Surg2010; 199(Suppl): S11–20.
11.
WhiteR.H., ZhouH., RomanoP.S.Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures.Thromb Haemost2003; 90: 446–55.
12.
AgnelliG., BolisG., CapussottiL.A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project.Ann Surg2006; 243: 89–95.
13.
OwensC.D., StoesselK.Surgical site infections: epidemiology, microbiology and prevention.J Hosp Infect2008; 70(suppl 2): 3–10.
14.
Centers for Medicare and Medicaid Services. Available at: www.cms.gov/HospitalAcqCond. Accessed November 21, 2010.
15.
MurrayB.W., HuertaS., DineenS., AnthonyT.Surgical site infection in colorectal surgery: a review the nonpharmacologic tools of prevention.J Am Coll Surg2010; 211: 812–22.
16.
KirbyJ.P., MazuskiJ.E.Prevention of surgical site infection.Surg Clin North Am2009; 89: 365–89, viii.
